Literature DB >> 32030543

The emerging role of hearing loss rehabilitation in patients with vestibular schwannoma treated with Gamma Knife radiosurgery: literature review.

Carlotta Morselli1, N Boari2, M Artico3, M Bailo2, L O Piccioni2, I Giallini3, M de Vincentiis3, P Mortini2, P Mancini3.   

Abstract

Stereotactic radiosurgery (SRS) is currently the most common treatment for small- to medium-size vestibular schwannoma (VS). Despite favorable outcome, hearing deterioration still remains an underestimated problem, and the role of hearing rehabilitation is an underinvestigated topic. Among available technologies, cochlear implant (CI) should represent a valid alternative in sporadic VS with single-sided deafness and in neurofibromatosis (NF2) with bilateral profound hearing loss. A literature review of the current clinical data was performed searching scientific literature databases. From all of the articles found, 16 papers were selected. Forty-four subjects treated with radiosurgery (18 male, 19 female, and in 7 cases, sex were not specified; 43 NF2 and 1 sporadic VS) were included in the analysis. Epidemiological, clinical, tumor, treatment, and audiological data were collected. Clinical outcome at last follow-up showed an audiological improvement in 25 of the 44 patients. The audiological outcome was unchanged in 16 cases. Audiological deterioration was recorded in 3 cases. Severity of NF2 phenotype, long history of ipsilateral profound deafness before implantation, progressive tumor growth, and high radiation dose (20 and 40 Gy) were found in patients with a worst audiological outcome. Hearing rehabilitation can improve audiological results for VS patients following SRS in selected cases. Hearing rehabilitation with cochlear implant (CI) in SSD leads to partial restoration of binaural hearing with an improvement in speech comprehension in noise and in sound localization, and partial suppression of subjective incapacitating tinnitus. SRS followed by CI may represent in selected cases a potential emerging option in the management of these patients, aimed at improving their quality of life. Possible implications for the follow-up of these patients are still present, although partially resolved.

Entities:  

Keywords:  Cochlear implant; Gamma Knife; Hearing loss; Hearing restoration; Stereotactic radiosurgery; Vestibular schwannoma

Mesh:

Year:  2020        PMID: 32030543     DOI: 10.1007/s10143-020-01257-8

Source DB:  PubMed          Journal:  Neurosurg Rev        ISSN: 0344-5607            Impact factor:   3.042


  68 in total

1.  Patient outcomes after vestibular schwannoma management: a prospective comparison of microsurgical resection and stereotactic radiosurgery.

Authors:  Bruce E Pollock; Colin L W Driscoll; Robert L Foote; Michael J Link; Deborah A Gorman; Christopher D Bauch; Jayawant N Mandrekar; Karl N Krecke; Craig H Johnson
Journal:  Neurosurgery       Date:  2006-07       Impact factor: 4.654

2.  Gamma Knife radiosurgery for vestibular schwannoma: clinical results at long-term follow-up in a series of 379 patients.

Authors:  Nicola Boari; Michele Bailo; Filippo Gagliardi; Alberto Franzin; Marco Gemma; Antonella del Vecchio; Angelo Bolognesi; Piero Picozzi; Pietro Mortini
Journal:  J Neurosurg       Date:  2014-12       Impact factor: 5.115

Review 3.  Microsurgery versus stereotactic radiation for small vestibular schwannomas: a meta-analysis of patients with more than 5 years' follow-up.

Authors:  Anastasios Maniakas; Issam Saliba
Journal:  Otol Neurotol       Date:  2012-12       Impact factor: 2.311

4.  The Changing Landscape of Vestibular Schwannoma Management in the United States--A Shift Toward Conservatism.

Authors:  Matthew L Carlson; Elizabeth B Habermann; Amy E Wagie; Colin L Driscoll; Jamie J Van Gompel; Jeffrey T Jacob; Michael J Link
Journal:  Otolaryngol Head Neck Surg       Date:  2015-06-30       Impact factor: 3.497

5.  Gamma Knife Radiosurgery as Primary Treatment for Large Vestibular Schwannomas: Clinical Results at Long-Term Follow-Up in a Series of 59 Patients.

Authors:  Michele Bailo; Nicola Boari; Alberto Franzin; Filippo Gagliardi; Alfio Spina; Antonella Del Vecchio; Marco Gemma; Angelo Bolognesi; Pietro Mortini
Journal:  World Neurosurg       Date:  2016-08-13       Impact factor: 2.104

6.  Morbidity and mortality following acoustic neuroma excision in the United States: analysis of racial disparities during a decade in the radiosurgery era.

Authors:  Shearwood McClelland; Hongfei Guo; Kolawole S Okuyemi
Journal:  Neuro Oncol       Date:  2011-08-19       Impact factor: 12.300

7.  Incidence of vestibular schwannoma and neurofibromatosis 2 in the North West of England over a 10-year period: higher incidence than previously thought.

Authors:  D Gareth R Evans; Anthony Moran; Andrew King; S Saeed; Nihal Gurusinghe; Richard Ramsden
Journal:  Otol Neurotol       Date:  2005-01       Impact factor: 2.311

8.  Contemporary surgical management of vestibular schwannomas: analysis of complications and lessons learned over the past decade.

Authors:  Yoichi Nonaka; Takanori Fukushima; Kentaro Watanabe; Allan H Friedman; John H Sampson; John T Mcelveen; Calhoun D Cunningham; Ali R Zomorodi
Journal:  Neurosurgery       Date:  2013-06       Impact factor: 4.654

9.  Hearing improvement after bevacizumab in patients with neurofibromatosis type 2.

Authors:  Scott R Plotkin; Anat O Stemmer-Rachamimov; Fred G Barker; Chris Halpin; Timothy P Padera; Alex Tyrrell; A Gregory Sorensen; Rakesh K Jain; Emmanuelle di Tomaso
Journal:  N Engl J Med       Date:  2009-07-08       Impact factor: 91.245

Review 10.  Hearing preservation after stereotactic radiosurgery for vestibular schwannoma: a systematic review.

Authors:  Isaac Yang; Derrick Aranda; Seunggu J Han; Sravana Chennupati; Michael E Sughrue; Steven W Cheung; Lawrence H Pitts; Andrew T Parsa
Journal:  J Clin Neurosci       Date:  2009-03-20       Impact factor: 1.961

View more
  3 in total

1.  Establishment of nomograms for the prediction of useful hearing loss in patients with neurofibromatosis type 2.

Authors:  Shi-Wei Li; Jing Zhang; Han-Lu Tang; Peng Li; Bo Wang; Fu Zhao; Pi-Nan Liu
Journal:  J Neurooncol       Date:  2021-11-09       Impact factor: 4.130

2.  [Hearing classification in patients with vestibular schwannoma using German-language test procedures].

Authors:  T Rahne; S K Plontke; D Vordermark; C Strauss; C Scheller
Journal:  HNO       Date:  2020-09-25       Impact factor: 1.284

3.  Management of transmodiolar and transmacular cochleovestibular schwannomas with and without cochlear implantation.

Authors:  S K Plontke; P Caye-Thomasen; C Strauss; S Kösling; G Götze; U Siebolts; D Vordermark; L Wagner; L Fröhlich; T Rahne
Journal:  HNO       Date:  2021-01       Impact factor: 1.284

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.